Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001437749-16-034198

Director acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stein Robert Benjamin Director 2016-06-17 Grant or award +40,000 $1.25 $50,000 240,000 D
Loading xslF345X03/rdgdoc.xml…